Sanofi · Paris France (Euronext Paris: SAN)
Key Sanofi Financials
| Company Type | Public -(Euronext Paris: SAN) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Sales (mil.) | $47,086.4 |
| 2011 Employees | 113,719 |
Sanofi Income Statement
| Dec 11 | Dec 10 | Dec 09 | |
| Revenue | 47,086.4 | 42,452.8 | 44,069.5 |
| Cost of Goods Sold | 14,642.5 | 11,551.8 | 11,293.6 |
| Gross Profit | 32,443.9 | 30,901.0 | 32,775.9 |
| Gross Profit Margin | 68.9% | 72.8% | 74.4% |
| SG&A Expense | 11,464.7 | 10,027.8 | 10,498.2 |
| Depreciation & Amortization | 4,451.0 | 5,250.4 | 5,056.3 |
| Operating Income | 7,697.3 | 7,899.5 | 9,123.8 |
| Operating Margin | 16.3% | 18.6% | 20.7% |
| Nonoperating Income | 0.0 | 0.0 | 0.0 |
| Nonoperating Expenses | (553.4) | (479.7) | (430.0) |
| Income Before Taxes | 7,143.9 | 7,419.8 | 8,693.8 |
| Income Taxes | 611.1 | 1,645.9 | 1,954.9 |
| Net Income After Taxes | 6,532.8 | 5,773.9 | 6,738.9 |
| Continuing Operations | 7,646.3 | 7,069.9 | 7,905.5 |
| Discontinued Operations | -- | 511.5 | 250.8 |
| Total Operations | 7,646.3 | 7,244.9 | 7,545.8 |
| Total Net Income | 7,646.3 | 7,244.9 | 7,545.8 |
| Net Profit Margin | 16.2% | 17.1% | 17.1% |
| Diluted EPS from Total Net Income | 2.88 | 2.77 | 2.89 |
| Dividends per Share | 1.24 | 1.19 | 1.56 |
All amounts in millions of US Dollars except per share amounts.
Sanofi Balance Sheet
| Assets | Dec 11 | Dec 10 | Dec 09 |
| Current Assets | |||
| Cash | 5,538.9 | 8,567.4 | 6,724.6 |
| Net Receivables | 10,801.2 | 8,623.1 | 8,620.7 |
| Inventories | 8,127.1 | 6,652.5 | 6,369.1 |
| Other Current Assets | 3,457.1 | 2,718.0 | 3,412.4 |
| Total Current Assets | 27,924.4 | 26,561.0 | 25,126.9 |
| Net Fixed Assets | 14,438.3 | 10,807.0 | 11,222.0 |
| Other Noncurrent Assets | 92,168.9 | 75,623.9 | 78,377.4 |
| Total Assets | 134,531.6 | 112,991.9 | 114,726.2 |
| Liabilities | Dec 11 | Dec 10 | Dec 09 |
| Current Liabilities | |||
| Accounts Payable | 4,275.1 | 3,710.6 | 3,803.7 |
| Short-Term Debt | 3,948.7 | 2,073.9 | 4,107.6 |
| Other Current Liabilities | 9,994.0 | 7,582.8 | 7,803.8 |
| Total Current Liabilities | 18,217.8 | 13,367.3 | 15,715.0 |
| Long-Term Debt | 16,787.4 | 8,872.2 | 8,543.3 |
| Other Noncurrent Liabilities | 24,018.7 | 20,388.2 | 21,404.8 |
| Total Liabilities | 59,023.9 | 42,627.7 | 45,663.2 |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 75,507.7 | 70,364.1 | 69,063.0 |
| Total Equity | 75,507.7 | 70,364.1 | 69,063.0 |
| Shares Outstanding (thou.) | 2,681,837.6 | 2,621,995.6 | 2,636,958.1 |
All amounts in millions of US Dollars except per share amounts.
Sanofi Cash Flow Statement
| Dec 11 | Dec 10 | Dec 09 | |
| Net Operating Cash Flow | 12,516 | 12,933 | 12,204 |
| Net Investing Cash Flow | (19,744.9) | (4,483.2) | (10,443.7) |
| Net Financing Cash Flow | 3,885.6 | (6,158.2) | (1,127.9) |
| Net Change in Cash | (3,144.2) | 2,349.6 | 667.9 |
| Depreciation & Amortization | 4,451.0 | 5,250.4 | 5,056.3 |
| Capital Expenditures | (2,393.4) | (2,084.5) | (2,558.3) |
| Cash Dividends Paid | (1,865.6) | (4,158.5) | (4,124.7) |
All amounts in millions of US Dollars except per share amounts.